Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Miscellaneous (PNH)

Differential gene expression in hematopoietic progenitors from paroxysmal nocturnal hemoglobinuria patients reveals an apoptosis/immune response in ‘normal’ phenotype cells

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired stem cell disorder characterized clinically by intravascular hemolysis, venous thrombosis, and bone marrow failure. Despite elucidation of the biochemical and molecular defects in PNH, the pathophysiology of clonal expansion of glycosylphosphatidylinositol-anchored protein (GPI-AP)-deficient cells remains unexplained. In pursuit of evidence of differences between GPI-AP-normal and -deficient CD34 cells, we determined gene expression profiles of isolated marrow CD34 cells of each phenotype from PNH patients and healthy donors, using DNA microarrays. Pooled and individual patient samples revealed consistent gene expression patterns relative to normal controls. GPI-AP-normal cells from PNH patients showed upregulation of genes involved in apoptosis and the immune response. Conversely, genes associated with antiapoptotic function and hematopoietic cell proliferation and differentiation were downregulated in these cells. In contrast, the PNH clone of GPI-AP-deficient cells appeared more similar to CD34 cells of healthy individuals. Gene chip data were confirmed by other methods. Similar gene expression patterns were present in PNH that was predominantly hemolytic as in PNH associated with aplastic anemia. Our results implicate an environmental influence on hematopoietic cell proliferation, in which the PNH clone evades immune attack and destruction, while normal cells suffer a stress response followed by programmed cell death.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Hall C, Richards SJ, Hillmen P . The glycosylphosphatidylinositol anchor and paroxysmal nocturnal haemoglobinuria/aplasia model. Acta Haematol 2002; 108: 219–230.

    Article  CAS  Google Scholar 

  2. Rosse W . A brief history of PNH. In: Young NS, Moss J (eds). PNH and the GPI-linked Proteins. San Diego: Academic Press, 2000, pp 1–20.

    Google Scholar 

  3. Okuda K, Kanamaru A, Ueda E, Kitani T, Okada N, Okada H et al. Expression of decay-accelerating factor on hematopoietic progenitors and their progeny cells grown in cultures with fractionated bone marrow cells from normal individuals and patients with paroxysmal nocturnal hemoglobinuria. Exp Hematol 1990; 18: 1132–1136.

    CAS  PubMed  Google Scholar 

  4. Dunn DE, Yu J, Nagarajan S, Devetten M, Weichold FF, Medof ME et al. A knock-out model of paroxysmal nocturnal hemoglobinuria: Pig-a(−) hematopoiesis is reconstituted following intercellular transfer of GPI- anchored proteins. PNAS 1996; 93: 7938–7943.

    Article  CAS  Google Scholar 

  5. Rosti V, Tremmi G, Scares V, Pandolfi PP, Luzzatto L, Bessler M . Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion. J Din Invest 1997; 100: 1028–1036.

    CAS  Google Scholar 

  6. Kawagoe K, Kitamura D, Okabe M, Taniuchi I, Ikawa M, Watanabe T et al. Glycosylphosphatidylinositol-anchor-deficient mice: implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria. Blood 1996; 87: 3600–3606.

    CAS  PubMed  Google Scholar 

  7. Brodsky RA, Vala MS, Barber JP, Medof ME, Jones RJ . Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria. PNAS 1997; 94: 8756–8760.

    Article  CAS  Google Scholar 

  8. Ware RE, Nishimura J, Moody MA, Smith C, Rosse WF, Howard TA . The PIG-A mutation and absence of glycosylphosphatidylinositol-linked proteins do not confer resistance to apoptosis in paroxysmal nocturnal hemoglobinuria. Blood 1998; 92: 2541–2550.

    CAS  PubMed  Google Scholar 

  9. Chen R, Nagarajan S, Prince GM, Maheshwari U, Terstappen LW, Kaplan DR et al. Impaired growth and elevated Fas receptor expression in PIGA(+) stem cells in primary paroxysmal nocturnal hemoglobinuria. J Clin Invest 2000; 106: 689–696.

    Article  CAS  Google Scholar 

  10. Chen G, Kirby M, Zeng W, Young NS, Maciejewski JP . Superior growth of glycophosphatidylinositol-anchored protein-deficient progenitor cells in vitro is due to the higher apoptotic rate of progenitors with normal phenotype in vivo. Exp Hematol 2002; 30: 774–782.

    Article  CAS  Google Scholar 

  11. Walker J, Flower D, Rigley K . Microarrays in hematology. Curr Opin Hematol 2002; 9: 23–29.

    Article  Google Scholar 

  12. Polacek DC, Passerini AG, Shi C, Francesco NM, Manduchi E, Grant GR et al. Fidelity and enhanced sensitivity of differential transcription profiles following linear amplification of nanogram amounts of endothelial mRNA. Physiol Genomics 2003; 13: 147–156.

    Article  CAS  Google Scholar 

  13. Peng X, Wood CL, Blalock EM, Chen KC, Landfield PW, Stromberg AJ . Statistical implications of pooling NA samples for microarray experiments. BMC Bioinformatics 2003; 4: 26.

    Article  Google Scholar 

  14. Zhao H, Hastie T, Whitfield ML, Borresen-Dale AL, Jeffrey SS . Optimization and evaluation of T7 based RNA linear amplification protocols for cDNA microarray analysis. BMC Genomics 2002; 3: 31.

    Article  CAS  Google Scholar 

  15. Kendziorski CM, Zhang Y, Lan H, Attie AD . The efficiency of pooling mRNA in microarray experiments. Biostatistics 2003; 4: 465–477.

    Article  CAS  Google Scholar 

  16. Zeng W, Chen G, Kajigaya S, Nunez O, Charrow A, Billings EM et al. Gene expression profiling in CD34 cells identifies significant differences between aplastic anemia patients and health volunteers. Blood 2003; 103: 325–332.

    Article  Google Scholar 

  17. Chen G, Zeng Z, Miyazato A, Billings E, Maciejewski JP, Kajigaya S et al. Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities. Blood 2004; 104: 4210–4218.

    Article  CAS  Google Scholar 

  18. Livak KJ, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2(−ΔΔCT) Method. Methods 2001; 25: 402–408.

    Article  CAS  Google Scholar 

  19. Zang DY, Goodwin RG, Loken MR, Bryant E, Deeg HJ . Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis. Blood 2001; 98: 3058–3065.

    Article  CAS  Google Scholar 

  20. Peter ME, Krammer PH . Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr Opin Immunol 1998; 10: 545–551.

    Article  CAS  Google Scholar 

  21. Lane BR, Liu J, Bock PJ, Schols D, Coffey MJ, Stricter RM et al. Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma. J Virol 2002; 76: 11570–11583.

    Article  CAS  Google Scholar 

  22. Umemura M, Nishimura H, Yajima T, Wajjwalk W, Matsuguchi T, Takahashi M et al. Overexpression of interleukin-15 prevents the development of murine retrovirus-induced acquired immunodeficiency syndrome. FASEB J 2002; 16: 1755–1763.

    Article  CAS  Google Scholar 

  23. Soejima K, Rollins BJ . A functional IFN-gamma-inducible protein-10/CXCLlO-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan. J Immunol 2001; 167: 6576–6582.

    Article  CAS  Google Scholar 

  24. Albanese P, Chagraoui J, Charon M, Cocault L, Dusanter-Fourt I, Romeo PH et al. Forced expression of p21 in GPIIb-p21 transgenic mice induces abnormalities in the proliferation of erythroid and megakaryocyte progenitors and primitive hematopoietic cells. Exp Hematol 2002; 30: 1263–1272.

    Article  CAS  Google Scholar 

  25. Seki N, Hattori A, Hayashi A, Kozuma S, Ohira M, Hori T et al. Structure, expression profile and chromosomal location of an isolog ofDNA-PKcs interacting protein (KIP) gene. Biochim Biophys Acta 1999; l444: 143–147.

    Article  Google Scholar 

  26. Wang N, Morra M, Wu C, Gullo C, Howie D, Coyle T et al. CD150 is a member of a family of genes that encode glycoproteins on the surface of hematopoietic cells. Immunogenetics 2001; 53: 382–394.

    Article  CAS  Google Scholar 

  27. Rengarajan J, Mittelstadt PR, Mages HW, Gerth AJ, Kroczek RA, Ashwell JD et al. Sequential involvement of NFAT and Egr transcription factors in FasL regulation. Immunity 2000; 12: 293–300.

    Article  CAS  Google Scholar 

  28. Ogawa H, Ishiguro K, Gaubatz S, Livingston DM, Nakatani Y . A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in GO cells. Science 2002; 296: 1132–1136.

    Article  CAS  Google Scholar 

  29. Suzuki S, Hashino S, Yoshida S, Chiba K, Izumiyama K, Kurosawa M et al. delll(p11–13) with overexpression of Wilms' tumor gene during leukemic transformation of myelodysplastic syndrome. Ann Hematol 2002; 81: 605–608.

    Article  CAS  Google Scholar 

  30. Yamada S, Shiono S, Joo A, Yoshimura A . Control mechanism of JAK/STAT signal transduction pathway. FEBS Lett 2003; 534: 190–196.

    Article  CAS  Google Scholar 

  31. Coqueret O . Linking cyclins to transcriptional control. Gene 2002; 299: 35–55.

    Article  CAS  Google Scholar 

  32. Drexler HG . Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells. Leukemia 1996; 10: 588–599.

    CAS  PubMed  Google Scholar 

  33. Brunner T, Kasibhatia S, Pinkoski MJ, Frutschi C, Yoo NJ, Echeverri F et al. Expression of Fas ligand in activated T cells is regulated by c-Myc. J Biol Chem 2000; 275: 9767–9772.

    Article  CAS  Google Scholar 

  34. Iwamoto N, Kawaguchi T, Horikawa K, Nagakura S, Kagimoto T, Suda T et al. Preferential hematopoiesis by paroxysmal nocturnal hemoglobinuria clone engrafted in SCID mice. Blood 1996; 87: 4944–4948.

    CAS  PubMed  Google Scholar 

  35. Young NS, Maciejewski JP, Sloand E, Chen G, Zeng W, Risitano A et al. The relationship of aplastic anemia and PNH. Int J Hematol 2002; 76 (Suppl 2): 168–172.

    Article  Google Scholar 

  36. Maciejewski JP, Rivera C, Kook H, Dunn D, Young NS . Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol-anchored protein-deficient clones. Br J Haematol 2001; 115: 1015–1022.

    Article  CAS  Google Scholar 

  37. Fujimaki S, Harigae H, Sugawara T, Takasawa N, Sasaki T, Kaku M . Decreased expression of transcription factor GATA-2 in haematopoietic stem cells in patients with aplastic anaemia. Br J Haematol 2001; 113: 52–57.

    Article  CAS  Google Scholar 

  38. Lyakisheva A, Felda O, Ganser A, Schmidt RE, Schubert J . Paroxysmal nocturnal hemoglobinuria: differential gene expression of EGR-1 and TAXREB107. Exp Hematol 2002; 30: 18–25.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N S Young.

Additional information

Supplementary Information

Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu).

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, G., Zeng, W., Maciejewski, J. et al. Differential gene expression in hematopoietic progenitors from paroxysmal nocturnal hemoglobinuria patients reveals an apoptosis/immune response in ‘normal’ phenotype cells. Leukemia 19, 862–868 (2005). https://doi.org/10.1038/sj.leu.2403678

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403678

Keywords

This article is cited by

Search

Quick links